Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $48.9700 (-6.62%) ($48.9700 - $48.9700) on Tue. Feb. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.05% (three month average) | RSI | 28 | Latest Price | $48.9700(-6.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -9.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(62%) IBUY(59%) IWC(59%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -4.025% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-13%) TBT(-8%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.025% (StdDev 8.05%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $39.63(-19.07%) | Resistance Level | $59.68 | 5 Day Moving Average | $53.87(-9.1%) | 10 Day Moving Average | $56.39(-13.16%) | 20 Day Moving Average | $59.68(-17.95%) | To recent high | -46.1% | To recent low | 68.8% | Market Cap | $3.041b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |